McKesson Corporation MCK
NYSE · Healthcare · Medical - Distribution
$1,069.43
Close on Fri, 20 Nov 2026 · market value $123B
What the price is betting on
Below its recordAt $1,069, the price assumes revenue shrinks about 4% a year for five years, from $419B to about $348B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 6.6% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than MCK? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$1,713
Base
$2,001
Bull
$2,335
Today $1,069
- Bear $1,713. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $2,001. Cash flow grows 7% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $2,335. Cash flow grows 9% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2027$410B$435B, on the path
- FY2028$394B$465B, on the path
- FY2029$378B$496B, on the path
- FY2030$363B$522B, on the path
- FY2031$348B$570B, on the path
Each year's revenue at −4% growth from $419B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Distribution · listed on NYSE
- Revenue, FY2026
- $403B
- Growth, 3 years a year
- 13%
- Cash margin
- 1.3%
- Net debt
- $4.6B
- Shares, 3-year change
- −13%
- Dividend yield
- 0.3%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.